U.S. Markets close in 1 hr 31 mins
  • S&P 500

    3,464.36
    +37.44 (+1.09%)
     
  • Dow 30

    28,461.80
    +266.38 (+0.94%)
     
  • Nasdaq

    11,597.46
    +118.58 (+1.03%)
     
  • Russell 2000

    1,628.76
    +15.13 (+0.94%)
     
  • Crude Oil

    41.59
    +0.76 (+1.86%)
     
  • Gold

    1,917.00
    +5.30 (+0.28%)
     
  • Silver

    25.03
    +0.33 (+1.34%)
     
  • EUR/USD

    1.1834
    +0.0061 (+0.5207%)
     
  • 10-Yr Bond

    0.7910
    +0.0300 (+3.94%)
     
  • Vix

    28.54
    -0.64 (-2.19%)
     
  • GBP/USD

    1.2941
    +0.0001 (+0.0039%)
     
  • USD/JPY

    105.4460
    +0.0160 (+0.0152%)
     
  • BTC-USD

    11,934.92
    +877.91 (+7.94%)
     
  • CMC Crypto 200

    239.62
    +0.70 (+0.29%)
     
  • FTSE 100

    5,889.22
    +4.57 (+0.08%)
     
  • Nikkei 225

    23,567.04
    -104.09 (-0.44%)
     

Vaxart (VXRT) Surges: Stock Moves 8.1% Higher

Zacks Equity Research
·2 mins read

Vaxart, Inc. VXRT was a big mover last session, as the company saw its shares rise more than 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $4.78 –$9.51 in the past one-month time frame, witnessed a sharp increase yesterday.

The company has seen two negative estimate revisions in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few months, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Vaxart currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

VAXART, INC. Price

VAXART, INC. Price
VAXART, INC. Price

VAXART, INC. price | VAXART, INC. Quote

A better-ranked stock in the Medical – Drugs industry is Catalent, Inc. CTLT, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The Hottest Tech Mega-Trend of All

Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Catalent, Inc. (CTLT) : Free Stock Analysis Report
 
VAXART, INC. (VXRT) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research